Chris Markoch

Chris Markoch

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

Sycophantic Investors Keep Admiring Naked Stock’s New Clothes

Bullish investors can say what they like about NAKD stock, but no amount of compliments will convince me this stock isn't naked.

Hyliion Is Running Out of Time to Separate Itself From the EV Pack

Hyliion offers a transitional approach to a fossil-free future. However, as other technologies get closer to reality, HYLN stock looks like a poor choice.

Sundial Growers Stock Is A Speculative Trade, Not An Investment

SNDL stock has strong sentiment among both bulls and bears that makes it a volatile stock best avoided by less active investors.

Vaxart’s Compelling Story Will Take a Long Time to Play Out

As a company attempting to make oral vaccines, Vaxart has a compelling story. However VXRT stock looks to be many years away from paying off.

7 Best Retail Stocks to Buy for the Brick-and-Mortar Resurgence

Consumers are taking their pent-up demand outside their homes, and these seven retail stocks will be among the strongest performers in 2021.